Company
About InCarda
Our Team
Board of Directors
Investors
Advisory Board
Careers
Our Pipeline
Pipeline Overview
Orally Inhaled Flecainide for PAF
About Atrial Fibrillation
News
Contact
Company
About InCarda
Our Team
Board of Directors
Investors
Advisory Board
Careers
Our Pipeline
Pipeline Overview
Orally Inhaled Flecainide for PAF
About Atrial Fibrillation
News
Contact
Board of Directors
Daniel G. Welch
Biotechnology Executive
(Executive Chairman)
Carlos Schuler, Ph.D.
Chief Executive Officer & Co-Founder
InCarda Therapeutics
Isaac Cheng, M.D.
Morningside Venture
Johan Christenson, M.D., Ph.D.
HealthCap
Alan Colowick, M.D., M.P.H.
Matrix Capital Management
Andrew ElBardissi, M.D.
Deerfield Management
Louis G. Lange, M.D., Ph.D.
BOD Observer
For more information about InCarda:
Contact Us